Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.

Item

http://www.wikidata.org/entity/Q38773356

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antithymocyte globulin in allo ...... ion: benefits and limitations.

@en

type

Item

label

Antithymocyte globulin in allo ...... ion: benefits and limitations.

@en

prefLabel

Antithymocyte globulin in allo ...... ion: benefits and limitations.

@en

P1476

Antithymocyte globulin in allo ...... ion: benefits and limitations.

@en

P2093

Mehdi Hamadani

http://www.w3.org/2001/XMLSchema#string

Mohamed A Kharfan-Dabaja

http://www.w3.org/2001/XMLSchema#string

Taiga Nishihori

http://www.w3.org/2001/XMLSchema#string

Zaid Al-Kadhimi

http://www.w3.org/2001/XMLSchema#string

P2860

New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

Antithymocyte globulins suppress dendritic cell function by multiple mechanisms.

Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

P304

435-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT.15.128

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26973125

http://www.w3.org/2001/XMLSchema#string